Quintela Fandiño, Miguel Angel miguel.quintela@uam.es
Actividades
- Artículos 52
- Libros 0
- Capítulos de libro 0
- Congresos 1
- Documentos de trabajo 0
- Informes técnicos 1
- Proyectos de investigación 0
- Tesis dirigidas 1
- Patentes o licencias de software 0
Phase I clinical trial of nintedanib plus paclitaxel in early HER-2-negative breast cancer (CNIO-BR-01-2010/GEICAM-2010-10 study)
- Quintela-Fandino, M.
- Urruticoechea, A.
- Guerra, J.
- Gil, M.
- Gonzalez-Martin, A.
- Marquez, R.
- Hernandez-Agudo, E.
- Rodriguez-Martin, C.
- Gil-Martin, M.
- Bratos, R.
- Escudero, M. J.
- Vlassak, S.
- Hilberg, F.
- Colomer, R.;
British Journal Of Cancer (p. 1060-1064) - 1/1/2014
10.1038/bjc.2014.397 Ver en origen
- ISSN 00070920
Phase II trial of vinorelbine tartrate in patients with treatment-naive metastatic melanoma
- Jimeno, A
- Hitt, R
- Quintela-Fandino, M
- Cortes-Funes, H;
Anti-Cancer Drugs (p. 53-57) - 1/1/2005
10.1097/00001813-200501000-00007 Ver en origen
- ISSN 14735741
Phosphoproteomic analysis of neoadjuvant breast cancer suggests that increased sensitivity to paclitaxel is driven by CDK4 and filamin A
- Mouron S
- Bueno MJ
- Lluch A
- Manso L
- Calvo I
- Cortes J
- Garcia-Saenz JA
- Gil-Gil M
- Martinez-Janez N
- Apala JV
- Caleiras E
- Ximénez-Embún P
- Muñoz J
- Gonzalez-Cortijo L
- Murillo R
- Sánchez-Bayona R
- Cejalvo JM
- Gómez-López G
- Fustero-Torre C
- Sabroso-Lasa S
- Malats N
- Martinez M
- Moreno A
- Megias D
- Malumbres M
- Colomer R
- Quintela-Fandino M
Nature Communications - 1/12/2022
10.1038/s41467-022-35065-z Ver en origen
- ISSN 20411723
Prediction of Response to Targeted Therapies in Lung Cancer Using Dynamic Imaging: Still Far From Clinical Implementation
- Quintela-Fandino, Miguel
- Colomer, Ramon;
Journal Of Clinical Oncology (p. 3716-3718) - 20/9/2011
10.1200/jco.2011.37.1427 Ver en origen
- ISSN 0732183X
- iMarina
- iMarina
Primary pulmonary artery sarcoma: Report of three cases and review of the literature
- Manso, Luis
- Alvarez, Elena
- Quintela, Miguel
- Cortes-Funes, Hernan
- Hitt, Ricardo;
Clinical Lung Cancer (p. 277-281) - 1/1/2007
10.3816/clc.2007.n.007 Ver en origen
- ISSN 15257304
Prolonged estrogen deprivation triggers a broad immunosuppressive phenotype in breast cancer cells
- Hühn D
- Martí-Rodrigo P
- Mouron S
- Hansel C
- Tschapalda K
- Porebski B
- Häggblad M
- Lidemalm L
- Quintela-Fandino M
- Carreras-Puigvert J
- Fernandez-Capetillo O
Molecular Oncology (p. 148-165) - 1/1/2022
10.1002/1878-0261.13083 Ver en origen
- ISSN 15747891
Randomized Phase O/I Trial of the Mitochondrial Inhibitor ME-344 or Placebo Added to Bevacizumab in Early HER2-Negative Breast Cancer
- Quintela-Fandino, Miguel
- Morales, Serafin
- Cortes-Salgado, Alfonso
- Manso, Luis
- Apala, Juan V.
- Munoz, Manuel
- Gasol Cudos, Ariadna
- Salla Fortuny, Joel
- Gion, Maria
- Lopez-Alonso, Antonio
- Cortes, Javier
- Guerra, Juan
- Malon, Diego
- Caleiras, Eduardo
- Mulero, Francisca
- Mouron, Silvana;
Clinical Cancer Research (p. 35-45) - 1/1/2020
10.1158/1078-0432.ccr-19-2023 Ver en origen
- ISSN 15573265
Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration
- Bossuyt V
- Provenzano E
- Symmans WF
- Boughey JC
- Coles C
- Curigliano G
- Dixon JM
- Esserman LJ
- Fastner G
- Kuehn T
- Peintinger F
- Von Minckwitz G
- White J
- Yang W
- Badve S
- Denkert C
- MacGrogan G
- Penault-Llorca F
- Viale G
- Cameron D
- Davidson NE
- Piccart M
- Norton L
- Earl H
- Alba E
- Lluch A
- Albanell J
- Amos K
- Becette V
- Biernat W
- Bonnefoi H
- Buzdar A
- Cane P
- Pinder S
- Carson L
- Dickson-Witmer D
- Gong G
- Green J
- Hsu CY
- Tseng LM
Annals Of Oncology (p. 1280-1291) - 1/7/2015
10.1093/annonc/mdv161 Ver en origen
- ISSN 09237534
Revisiting the Revolution: Examining the Evolving Role of Antiangiogenic Therapy in Cancer
- Quintela-Fandino, Miguel
- Ebos, John M. L.;
Current Drug Targets (p. 1706-1706) - 1/1/2016
10.2174/1389450117999160425123635 Ver en origen
- ISSN 13894501
Selective activity over a constitutively active RET-variant of the oral multikinase inhibitor dovitinib: Results of the CNIO-BR002 phase I-trial
- Quintela-Fandino, Miguel
- Bueno, Maria J.
- Lombardia, Luis
- Gil, Marta
- Gonzalez-Martin, Antonio
- Marquez, Raul
- Bratos, Raquel
- Guerra, Juan
- Tan, Eugene
- Lopez, Antonio
- Colomer, Ramon
- Salazar, Ramon;
Molecular Oncology (p. 1719-1728) - 1/12/2014
- ISSN 15747891
- iMarina
Este/a investigador/a no tiene libros.
Este/a investigador/a no tiene capítulos de libro.
Phase I clinical trial of neoadjuvant BIBF1120 plus weekly paclitaxel (P) in early HER-2 negative breast cancer. CNIO-BR-01-2010 GEICAM 2010-10 study
- Quintela-Fandino, M.
- Urruticoechea, A.
- Guerra, J.
- Gil, M.
- Gonzalez-Martin, A.
- Marquez, R.
- Hernandez-Agudo, E.
- Rodriguez-Martin, C.
- Gil, M.
- Bratos, R.
- Escudero, M. J.
- Colomer, R.;
Cancer Research - 15/12/2013
10.1158/0008-5472.sabcs13-pd5-8 Ver en origen
- ISSN 00085472
Este/a investigador/a no tiene documentos de trabajo.
A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3K?/?, in Patients with Advanced Solid Tumors
- Choudhury AD, Higano CS, de Bono JS, Cook N, Rathkopf DE, Wisinski KB, Martin-Liberal J, Linch M, Heath EI, Baird RD, García-Carbacho J, Quintela-Fandino M, Barry ST, de Bruin EC, Colebrook S, Hawkins G, Klinowska T, Maroj B, Moorthy G, Mortimer PG, Moschetta M, Nikolaou M, Sainsbury L, Shapiro GI, Siu LL, Hansen AR
Clinical Cancer Research (p. 2257-2269) - 1/1/2022
10.1158/1078-0432.ccr-21-3087 Ver en origen
- ISSN 15573265
Este/a investigador/a no tiene proyectos de investigación.
Este/a investigador/a no tiene patentes o licencias de software.
Perfiles de investigador/a
-
ORCID
-
Scopus Author ID
-
Dialnet id